These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 33263622)

  • 1. Potential mouth rinses and nasal sprays that reduce SARS-CoV-2 viral load: What we know so far?
    de Toledo Telles-Araujo G; Caminha RDG; Kallás MS; Sipahi AM; da Silva Santos PS
    Clinics (Sao Paulo); 2020 Nov; 75():e2328. PubMed ID: 33263622
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of Mouth Rinses and Nasal Spray in the Inactivation of SARS-CoV-2: A Systematic Review and Meta-Analysis of
    Idrees M; McGowan B; Fawzy A; Abuderman AA; Balasubramaniam R; Kujan O
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could nasal irrigation and oral rinse reduce the risk for COVID-19 infection?
    Casale M; Rinaldi V; Sabatino L; Moffa A; Ciccozzi M
    Int J Immunopathol Pharmacol; 2020; 34():2058738420941757. PubMed ID: 32799596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial.
    Alzahrani MM; Bamashmous S; Alkharobi H; Alghamdi A; Alharbi RH; Hassan AM; Darwish M; Bukhari A; Mahmoud AB; Alfaleh MA; Mirza AA; Abuzenadah AM; Abujamel TS; Hashem AM
    J Med Virol; 2023 Jan; 95(1):e28412. PubMed ID: 36527332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2.
    Meister TL; Todt D; Brüggemann Y; Steinmann J; Banava S; Brill FHH; Steinmann J; Pfaender S; Steinmann E
    J Hosp Infect; 2022 Feb; 120():9-13. PubMed ID: 34752803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial.
    Guenezan J; Garcia M; Strasters D; Jousselin C; Lévêque N; Frasca D; Mimoz O
    JAMA Otolaryngol Head Neck Surg; 2021 Apr; 147(4):400-401. PubMed ID: 33538761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19.
    Baker N; Williams AJ; Tropsha A; Ekins S
    Pharm Res; 2020 May; 37(6):104. PubMed ID: 32451736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control.
    Hoseini-Tavassol Z; Ejtahed HS; Soroush AR; Sajjadpour Z; Hasani-Ranjbar S; Larijani B
    Infect Disord Drug Targets; 2021; 21(8):e160921191568. PubMed ID: 33602078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2.
    Meister TL; Brüggemann Y; Todt D; Conzelmann C; Müller JA; Groß R; Münch J; Krawczyk A; Steinmann J; Steinmann J; Pfaender S; Steinmann E
    J Infect Dis; 2020 Sep; 222(8):1289-1292. PubMed ID: 32726430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial.
    Carrouel F; Viennot S; Valette M; Cohen JM; Dussart C; Bourgeois D
    Trials; 2020 Nov; 21(1):906. PubMed ID: 33138848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the oral cavity relevant in SARS-CoV-2 pandemic?
    Herrera D; Serrano J; Roldán S; Sanz M
    Clin Oral Investig; 2020 Aug; 24(8):2925-2930. PubMed ID: 32577830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virucidal effects of mouthwashes or mouth rinses: a world of caution for molecular detection of SARS-CoV-2 in saliva.
    Lippi G; Nocini R; Henry BM; Plebani M
    Diagnosis (Berl); 2022 Jan; 9(2):285-287. PubMed ID: 35092657
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2.
    Carrouel F; Gonçalves LS; Conte MP; Campus G; Fisher J; Fraticelli L; Gadea-Deschamps E; Ottolenghi L; Bourgeois D
    J Dent Res; 2021 Feb; 100(2):124-132. PubMed ID: 33089717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Concept for the Reduction of Mucosal SARS-CoV-2 Load using Hypochloric Acid Solutions.
    Mueller CA; Winter M; Renner B
    Drug Res (Stuttg); 2021 Jul; 71(6):348-350. PubMed ID: 33890267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective
    Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of oral antiseptics for SARS-CoV-2 infection.
    Palop Larrea V; Hernández Rodríguez MÁ
    Med Clin (Barc); 2020 Nov; 155(9):416-417. PubMed ID: 32778429
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2.
    Ferrer MD; Barrueco ÁS; Martinez-Beneyto Y; Mateos-Moreno MV; Ausina-Márquez V; García-Vázquez E; Puche-Torres M; Giner MJF; González AC; Coello JMS; Rueda IA; Aubá JMV; Español CC; Velasco AL; Abad DS; García-Esteban S; Artacho A; López-Labrador X; Mira A
    Sci Rep; 2021 Dec; 11(1):24392. PubMed ID: 34937855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could mouth rinses be an adjuvant in the treatment of SARS-CoV-2 patients? An appraisal with a systematic review.
    Gandhi G; Thimmappa L; Upadhya N; Carnelio S
    Int J Dent Hyg; 2022 Feb; 20(1):136-144. PubMed ID: 34628705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.
    Muñoz-Basagoiti J; Perez-Zsolt D; León R; Blanc V; Raïch-Regué D; Cano-Sarabia M; Trinité B; Pradenas E; Blanco J; Gispert J; Clotet B; Izquierdo-Useros N
    J Dent Res; 2021 Oct; 100(11):1265-1272. PubMed ID: 34282982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
    Khan FR; Kazmi SMR; Iqbal NT; Iqbal J; Ali ST; Abbas SA
    Trials; 2020 Sep; 21(1):785. PubMed ID: 32928313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.